BTFL — Bountiful Co Income Statement
0.000.00%
HealthcareMicro Cap
Annual income statement for Bountiful Co, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2018 September 30th | 2019 September 30th | 2020 September 30th | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 1,900 | 1,882 | 2,069 |
Cost of Revenue | |||
Gross Profit | 612 | 682 | 793 |
Selling / General / Administrative Expenses | |||
Depreciation and Amortization | |||
Unusual Expense / Income | |||
Total Operating Expenses | 1,878 | 1,894 | 1,872 |
Operating Profit | 22.4 | -12.3 | 197 |
Gain / Loss on Sale of Assets | |||
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | -110 | -152 | 81.6 |
Provision for Income Taxes | |||
Net Income After Taxes | 158 | -114 | 69.9 |
Minority Interest | |||
Net Income Before Extraordinary Items | |||
Net Income | 156 | -114 | 69.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | 156 | -114 | 69.9 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | 35.8 | -3.56 | 15.2 |
Dividends per Share |